NEOGENOMICS INC's ticker is and the CUSIP is 64049MAB6. A total of 31 filers reported holding NEOGENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,017,058 | -2.1% | 7,708,000 | 0.0% | 0.02% | -13.6% |
| Q1 2024 | $6,147,130 | +4.2% | 7,708,000 | 0.0% | 0.02% | +22.2% |
| Q4 2023 | $5,898,355 | +6.0% | 7,708,000 | 0.0% | 0.02% | -28.0% |
| Q3 2023 | $5,564,405 | -13.8% | 7,708,000 | -11.5% | 0.02% | -21.9% |
| Q2 2023 | $6,454,805 | +0.2% | 8,708,000 | 0.0% | 0.03% | -3.0% |
| Q1 2023 | $6,443,920 | +51.1% | 8,708,000 | +34.0% | 0.03% | +6.5% |
| Q4 2022 | $4,265,950 | +64.0% | 6,500,000 | +62.5% | 0.03% | +93.8% |
| Q3 2022 | $2,601,000 | +58.7% | 4,000,000 | +60.0% | 0.02% | +220.0% |
| Q1 2022 | $1,639,000 | -86.0% | 2,500,000 | -78.3% | 0.01% | -78.3% |
| Q3 2021 | $11,687,000 | +26.0% | 11,500,000 | +21.1% | 0.02% | +9.5% |
| Q2 2021 | $9,274,000 | +41.1% | 9,500,000 | +46.2% | 0.02% | +10.5% |
| Q1 2021 | $6,572,000 | – | 6,500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERBACK ASSET MANAGEMENT LLC | 12,768,000 | $9,392,460 | 1.28% |
| BRAIDWELL LP | 48,678,000 | $36,082,568 | 1.18% |
| LINDEN ADVISORS LP | 85,576,000 | $62,776,354 | 0.66% |
| SHENKMAN CAPITAL MANAGEMENT INC | 9,333,000 | $6,928,845 | 0.54% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 27,718,000 | $20,545,968 | 0.40% |
| CAMDEN ASSET MANAGEMENT L P /CA | 8,000,000 | $5,850,000 | 0.20% |
| Calamos Advisors LLC | 46,132,000 | $33,853,507 | 0.17% |
| OAKTREE CAPITAL MANAGEMENT LP | 12,276,000 | $9,099,585 | 0.12% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 7,500,000 | $5,549,144 | 0.12% |
| CSS LLC/IL | 805,000 | $593,868 | 0.04% |